SD Biosensor

SD Biosensor P/CF

The P/CF (Price-to-Cash-Flow Ratio) of SD Biosensor (137310.KS) as of Oct 21, 2026 is 2.50. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 5.71 — a change of -56.22% (lower).

P/CF

2.50

YoY

-56.22%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of SD Biosensor is 2025 2.50 . P/CF (Price-to-Cash-Flow Ratio) of SD Biosensor was 2024 5.71 . It decreases by -56.22% lower compared to the previous year.

The SD Biosensor P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2019
-549.96 KRW
Jan 1, 2020
1.80 KRW
Jan 1, 2021
0.72 KRW
Jan 1, 2022
1.00 KRW
Jan 1, 2023
-3.69 KRW
Jan 1, 2024
5.71 KRW
Jan 1, 2025
2.50 KRW
The SD Biosensor P/CF history
YEARP/CFYoY
2.50-56.22%
5.71-254.81%
-3.69-467.38%
1.00+38.72%
0.72-59.89%
1.80-100.33%
-549.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SD Biosensor stock

P/CF (Price-to-Cash-Flow Ratio) of SD Biosensor is 2.50 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of SD Biosensor changed from 5.71 to 2.50, representing a -56.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s SD Biosensor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — SD Biosensor

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — SD Biosensor